Document Detail


An odontogenic keratocystic tumor in the buccal space: an unusual site of origin and a review of the literature.
MedLine Citation:
PMID:  22949600     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Keratocystic odontogenic tumors (KCOTs) arise from remnants of epithelial structures associated with the development of teeth and occur predominantly intraosseously. In rare occasions they can appear extraosseously in the gingiva as peripheral counterparts; only 15 cases have been reported to date. Evenmore rare are cases of KCOTs of the buccal soft tissues. The aim of this report is to present a rare case of KCOT affecting the buccal soft tissue as an original site and a review of the literature regarding diagnostic and therapeutic options.
Authors:
Alexander Gröbe; Henning Hanken; Marco Blessmann; Jozef Zustin; Max Heiland; Ahmed Al-Dam
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  26     ISSN:  1791-7549     ISO Abbreviation:  In Vivo     Publication Date:    2012 Sep-Oct
Date Detail:
Created Date:  2012-09-05     Completed Date:  2013-01-16     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  847-51     Citation Subset:  IM    
Affiliation:
Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. a.groebe@uke.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Male
Middle Aged
Mouth Mucosa / pathology*,  surgery
Odontogenic Cysts / pathology,  radiography*,  surgery
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of sleep apnoea using a mandibular advancement splint - an open prospective study.
Next Document:  Obesity Effects on Cyclophosphamide-induced DNA Damage in Hematopoietic Cell Transplant Recipients.